search
Back to results

Effective Endurance Training in Metabolic Syndrome

Primary Purpose

Impaired Glucose Tolerance, Overweight, Hypertension

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
exercise training
Sponsored by
Norwegian University of Science and Technology
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Impaired Glucose Tolerance focused on measuring Exercise, Exercise therapy

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All Sexes

Inclusion Criteria: insulin resistance, impaired glucose tolerance or type 2-diabetes, including two or more of the following factors: Blood pressure ≥ 140/90 mm Hg, Triglycerides Fasting ≥ 1,7 mmol/l, and/or low HDL-cholesterol (≤ 0,9 mmol/l in men, ≤ 1,0 mmol/l in women) Obesity, Waist-hip ratio ≥ 0,9 in men, ≥ 0,85 in women or BMI (body mass index) ≥ 30 kg/m2 Microalbuminuria (albumin secretion ≥ 20 mg/l or 20 - 200 g per minute) Exclusion Criteria: -

Sites / Locations

  • The medical faculty at norwegian university of science and technology

Outcomes

Primary Outcome Measures

To reduce risk factors related to metabolic syndrome

Secondary Outcome Measures

Improve endothelial functions in patient with metabolic syndrome

Full Information

First Posted
September 20, 2005
Last Updated
March 29, 2017
Sponsor
Norwegian University of Science and Technology
search

1. Study Identification

Unique Protocol Identification Number
NCT00218998
Brief Title
Effective Endurance Training in Metabolic Syndrome
Official Title
Effective Endurance Training in Metabolic Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
January 2004 (Actual)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To see how fast and how much physical training can reduce risk factors related to metabolic syndrome

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Impaired Glucose Tolerance, Overweight, Hypertension, Dyslipidemia
Keywords
Exercise, Exercise therapy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Single
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
exercise training
Primary Outcome Measure Information:
Title
To reduce risk factors related to metabolic syndrome
Secondary Outcome Measure Information:
Title
Improve endothelial functions in patient with metabolic syndrome

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Eligibility Criteria
Inclusion Criteria: insulin resistance, impaired glucose tolerance or type 2-diabetes, including two or more of the following factors: Blood pressure ≥ 140/90 mm Hg, Triglycerides Fasting ≥ 1,7 mmol/l, and/or low HDL-cholesterol (≤ 0,9 mmol/l in men, ≤ 1,0 mmol/l in women) Obesity, Waist-hip ratio ≥ 0,9 in men, ≥ 0,85 in women or BMI (body mass index) ≥ 30 kg/m2 Microalbuminuria (albumin secretion ≥ 20 mg/l or 20 - 200 g per minute) Exclusion Criteria: -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ulrik E Wisløff, Phd prof
Organizational Affiliation
National Taiwan Normal University
Official's Role
Study Chair
Facility Information:
Facility Name
The medical faculty at norwegian university of science and technology
City
Trondheim
ZIP/Postal Code
7489
Country
Norway

12. IPD Sharing Statement

Citations:
PubMed Identifier
19255350
Citation
Poelkens F, Hopman MT, Tack CC. Letter by Poelkens et al regarding article, "Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study". Circulation. 2009 Mar 3;119(8):e225; author reply e226. doi: 10.1161/CIRCULATIONAHA.108.818765. No abstract available.
Results Reference
background
PubMed Identifier
18606913
Citation
Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, Loennechen JP, Al-Share QY, Skogvoll E, Slordahl SA, Kemi OJ, Najjar SM, Wisloff U. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008 Jul 22;118(4):346-54. doi: 10.1161/CIRCULATIONAHA.108.772822. Epub 2008 Jul 7.
Results Reference
result

Learn more about this trial

Effective Endurance Training in Metabolic Syndrome

We'll reach out to this number within 24 hrs